Search Results for: immunocompromised patients

Efficacy and safety of antiviral plus anti-spike monoclonal antibody combination therapy versus monotherapy for high-risk immunocompromised patients with mild to moderate SARS-CoV2 infection during Omicron era. A prospective cohort study.

Coronavirus Literature
Publication date: Jan 18, 2024 Antivirals and monoclonal antibodies are available to lower progression risk in immunocompromised patients. However, combination therapy with both types of agents has not been studied. ... Read more